Webinar on Global Partnership with Sapphire Medical Clinics
Filed with ASX · · 2 pages · English
Emyria Limited (ASX: EMD) (Emyria or the Company),a company that manages an Australia-wide clinical service for patients with unmet medical needs (Emerald Clinics) and also develops and commercialises clinical technologies and data products, is pleased to invite investors and shareholders to an online Investor Briefing. Chief Executive Officer, Michael Winlo will be providing an update to the mark
Earlier from Emyria
- Emyria Signs Real-World Data Agreement with Zelira
- Preliminary Final Report and Full Year Statutory Accounts
- Emerald Clinics Successfully Raises $2.2m in Placement
- Record Appointments International Expansion and Name Change
- Emerald Signs RWE Contract with Canopy Growth UK Company
Later from Emyria
- Emyria Enters Data Deal with ZLD to Support Autism Trial
- Emyria Partners with Thought Leaders in Psychedelic Therapy
- Emyria Launches Drug Development Program Based on RWE
- Emyria Sees Strong Interest in IBS Study
- Emyria to Benefit from Final TGA Ruling on CBD Medicines
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria